Enhancement of macrophage superoxide anion production by amphotericin B.
AUTOR(ES)
Wilson, E
RESUMO
Amphotericin B (AmB) appears to have some important immunomodulatory effects, but its mechanism of action has not been explained. We investigated the effects of AmB on activation of human monocyte-derived macrophages. Macrophages cultured in the presence of AmB had an enhanced capacity to produce superoxide anion after stimulation with phorbol myristate acetate. This enhancement was dose dependent within a therapeutic range of AmB levels (0.1 to 3.0 mg/liter). Macrophages cultured in the presence of AmB had enhanced surface expression of Ia antigen; phagocytosis of unopsonized zymosan, opsonized Staphylococcus aureus, or erythrocytes opsonized with C3bi or immunoglobulin G paradoxically appeared to be reduced, but results did not achieve statistical significance. AmB appears to activate macrophages and may do so via direct effects on the plasma membrane.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=245109Documentos Relacionados
- Enhancement of platelet function by superoxide anion.
- In vivo activation of macrophage oxidative burst activity by cytokines and amphotericin B.
- Enhancement of rIn:rCn-Induced Interferon Production by Amphotericin B
- Enhancement of nitric oxide synthesis by macrophages represents an additional mechanism of action for amphotericin B.
- Enhancement of chemotactic peptide-induced activation of phosphoinositide 3-kinase by granulocyte-macrophage colony-stimulating factor and its relation to the cytokine-mediated priming of neutrophil superoxide-anion production.
